Multiple Sclerosis Drug Price Qui Tam Suit Dismissed On Government’s Motion

Mealey's (November 6, 2019, 11:25 AM EST) -- PROVIDENCE, R.I. — A Rhode Island federal judge on Oct. 21 issued an opinion explaining why he dismissed with prejudice a false claims lawsuit alleging that makers of multiple sclerosis (MS) drugs overpaid service fees to pharmacy benefit managers (PBMs) to inflate prices paid by the Medicare drug program (United States ex rel. John R. Borzilleri, M.D. v. Bayer Healthcare Pharmaceuticals, Inc., et al., No. 14-31, D. R.I., 2019 U.S. Dist. LEXIS 181418)....

Attached Documents

Related Sections